SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Real-world data: a comprehensive literature review on the barriers, challenges, and opportunities associated with their inclusion in the health technology assessment process
13 references·1 citing·40 second hop
Real-world data: a comprehensive literature review on the barriers, challenges, and opportunities associated with their inclusion in the health technology assessment process (2024)Real-world data: a comprehensive literatu…Real-World Evidence: A Primer (2023)Real-World Evidence: A PrimerReal-World Evidence—Current Developments and Perspectives (2022)Real-World Evidence—Current D…Use of External Comparators for Health Technology Assessment Submissions Based on Single-Arm Trials (2021)Use of External Comparators f…The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021)The PRISMA 2020 statement: an…Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU—actions for stakeholders (2020)Real-world evidence to suppor…Optimising the value of the critical appraisal skills programme (CASP) tool for quality appraisal in qualitative evidence synthesis (2020)Optimising the value of the c…Implementation of Health Technology Assessment in the Middle East and North Africa: Comparison Between the Current and Preferred Status (2020)Implementation of Health Tech…Real-World Evidence in Healthcare Decision Making: Global Trends and Case Studies From Latin America (2019)Real-World Evidence in Health…Real-world evidence for coverage decisions: opportunities and challenges (2018)Real-world evidence for cover…Using Real-World Data in Health Technology Assessment (HTA) Practice: A Comparative Study of Five HTA Agencies (2017)Using Real-World Data in Heal…Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies (2017)Policies for Use of Real-Worl…Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Preferred Reporting Items for…Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred reporting items for…HR’S ROLE IN ORGANIZATIONAL CHANGE WITHIN NIGERIA’S RENEWABLE ENERGY SECTOR: A REVIEW (2023)HR’S ROLE IN ORGANIZATIONAL C…The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies (2007)The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009)The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration (2009)PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation (2018)Three Approaches to Qualitative Content Analysis (2005)Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups (2007)Using Real-World Data for Coverage and Payment Decisions: The ISPOR Real-World Data Task Force Report (2007)Critical appraisal of nonrandomized studies—A review of recommended and commonly used tools (2018)Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing—Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative (2020)Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions (2022)The Measurement of Observer Agreement for Categorical Data (1977)Methods for the economic evaluation of health care programmes (1987)Methods for the Economic Evaluation of Health Care Programmes (2005)The Role of Digital Strategies in Financing Health Care for Universal Health Coverage in Low- and Middle-Income Countries (2018)Current challenges for assessing the long-term clinical benefit of cancer immunotherapy: a multi-stakeholder perspective (2020)Real World Data in Health Technology Assessment of Complex Health Technologies (2022)Reporting bias in medical research - a narrative review (2010)Standards and guidelines for observational studies: quality is in the eye of the beholder (2015)The Expanding Role of Real-World Evidence Trials in Health Care Decision Making (2019)Framework for the synthesis of non-randomised studies and randomised controlled trials: a guidance on conducting a systematic review and meta-analysis for healthcare decision making (2020)Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications (2021)Generalized cost-effectiveness analysis for national-level priority-setting in the health sector (2003)Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force (2016)On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review (2018)Green Innovation in the MENA Healthcare Industry (2022)Revision of Malawi’s Health Benefits Package: A Critical Analysis of Policy Formulation and Implementation (2023)Naturalistic inquiry (1985)Reflecting on reflexive thematic analysis (2019)Extreme events and gender-based violence: a mixed-methods systematic review (2022)Barriers and facilitators to diet, physical activity and lifestyle behavior intervention adherence: a qualitative systematic review of the literature (2023)Inter-Coder Agreement in Qualitative Coding: Considerations for its Use (2024)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. (2009)Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic (2021)PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews (2021)PRISMA2020 : An R package and Shiny app for producing PRISMA 2020‐compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis (2022)Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement (1999)The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (2001)Are supplemental appraisal/reimbursement processes needed for rare disease treatments? An international comparison of country approaches (2020)Implementing Outcomes-Based Managed Entry Agreements for Rare Disease Treatments: Nusinersen and Tisagenlecleucel (2021)Data Quality–Driven Improvement in Health Care: Systematic Literature Review (2024)
this work references cited by second hop

References

  • 2021The PRISMA 2020 statement: an updated guideline for reporting systematic reviews119,202 cited
  • 2009Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement84,364 cited
  • 2009Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement65,829 cited
  • 2020Optimising the value of the critical appraisal skills programme (CASP) tool for quality appraisal in qualitative evidence synthesis1,198 cited
  • 2023Real-World Evidence: A Primer246 cited
  • 2017Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies206 cited
  • 2017Using Real-World Data in Health Technology Assessment (HTA) Practice: A Comparative Study of Five HTA Agencies112 cited
  • 2018Real-world evidence for coverage decisions: opportunities and challenges94 cited
  • 2020Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU—actions for stakeholders78 cited
  • 2020Implementation of Health Technology Assessment in the Middle East and North Africa: Comparison Between the Current and Preferred Status74 cited
  • 2021Use of External Comparators for Health Technology Assessment Submissions Based on Single-Arm Trials74 cited
  • 2019Real-World Evidence in Healthcare Decision Making: Global Trends and Case Studies From Latin America73 cited
  • 2022Real-World Evidence—Current Developments and Perspectives

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

73 cited

Cited by

  • 2023HR’S ROLE IN ORGANIZATIONAL CHANGE WITHIN NIGERIA’S RENEWABLE ENERGY SECTOR: A REVIEW14 cited